Sulforaphane (Broccoli Extract).

Glutathione is built from glutamate, cysteine and glycine, and glutamine is the main circulating source of the glutamate carbon. Sulforaphane raises expression of the glutathione synthesis enzymes through Nrf2, which increases demand for all three amino acid inputs. Supplying the substrate alongside the inducer is a standard construction.

Cysteine, the rate-limiting amino acid for glutathione, comes largely from methionine through the transsulfuration pathway. Sulforaphane induces the glutathione synthesis machinery, so cysteine supply becomes the constraint. Methionine is one upstream route to that supply, alongside dietary cysteine itself.

When plant myrosinase has been inactivated by heat, glucoraphanin reaching the colon is hydrolysed to sulforaphane by bacterial thioglucosidase activity instead. Certain lactobacilli carry that activity, which is why conversion varies so widely between people. Pairing an organism with the precursor is a mechanistic rationale rather than a measured co-administration outcome.

Colonic bacteria are the fallback route for converting glucoraphanin into sulforaphane when the plant enzyme is absent. Bifidobacteria are among the genera reported to carry glucosinolate-hydrolysing activity. The size of the resulting conversion differs person to person and is not predictable from the dose.

Because glucoraphanin conversion depends on the colonic community when myrosinase is absent, anything that shifts that community can shift conversion. Resistant starch is a well characterised fermentable substrate for the relevant saccharolytic groups. This is an indirect, substrate-level rationale and it has not been measured as a combination.

GOS selectively feeds bifidobacteria, one of the genera credited with bacterial glucoraphanin hydrolysis. The reasoning runs through the microbiome rather than through any direct chemical interaction. Read it as mechanistic rather than clinical.

Both compounds originate from glucosinolate breakdown in brassica: sulforaphane from glucoraphanin, DIM from the indole glucosinolate glucobrassicin by way of indole-3-carbinol. They act on partly overlapping phase II detoxification enzyme induction. A whole brassica extract supplies both, which is why co-formulation mirrors the food.

A 2026 review specifically surveying sulforaphane combinations with other phytochemicals describes overlapping and complementary signalling with plant flavonoids. Apigenin is a flavone with its own documented effects on the same antioxidant response machinery. The review is mechanistic and does not establish a measured combination benefit in people.

Luteolin is a flavone reported to modulate the same Nrf2 and Keap1 axis that sulforaphane acts on, though through different chemistry: sulforaphane modifies Keap1 cysteines directly, flavones act more indirectly. A 2026 review of sulforaphane phytochemical combinations covers this class. The grounding is mechanistic.

A systematic review of food-derived DNA methyltransferase modulators includes sulforaphane among the compounds reported to affect methyltransferase activity, and one-carbon nutrients supply the methyl groups those enzymes use. The two therefore sit on opposite sides of the same reaction. This is enzyme-level evidence, not an outcome.

Nrf2 activation increases transcription of ferritin heavy and light chains and of heme oxygenase-1, both of which change how cells hold and handle iron. Sulforaphane is a canonical Nrf2 activator, so it touches iron handling indirectly. This is a cellular handling effect, not a change in dietary iron requirement.

Lycopene is a lipophilic carotenoid that quenches singlet oxygen directly, while sulforaphane works indirectly by inducing the cell's own antioxidant enzymes. The two mechanisms are chemically distinct and non-overlapping. Both accumulate in prostate tissue, which is why they appear together in dietary studies.

Electrophilic oxidation products of long chain omega-3 fatty acids can modify Keap1 cysteines, the same switch sulforaphane acts on, though far less potently. Placing them together stacks two inputs onto one sensor. The interaction is described at the cell level and has not been quantified as a combination in people.

Vitamin D signalling through the vitamin D receptor and Nrf2 signalling intersect at several shared transcriptional targets in epithelial tissue. Sulforaphane engages the second of those. The crosstalk is reported in cell work and should be read as mechanistic.